UPDATE 1-Baby formula supplies improving, say U.S. retailers Walmart and Target [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
were improving, months after the country faced acute shortages that had caused a panic among parents. Considering the still-existing supply constraints, Target said it will continue with the purchase restrictions both at its stores and online. The shortage that began due to pandemic-induced supply chain issues worsened in February when Abbott Laboratories, the biggest U.S. supplier, recalled some products and closed a manufacturing plant after reports of bacterial infections. In response, U.S. health regulators relaxed import policies and shipped in millions of cans of emergency supplies from companies such as Nestle SA and Reckitt Benckiser . Abbott in early July partly restarted production of certain specialty and metabolic formulas at its Sturgis facility while also importing baby formula products from its international plants. Walmart Chief Financial Officer John David Rainey said on an earnings call on Tuesday the shortage the company experienced in a “big way” in the s
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]Yahoo! Finance
- Global Cancer Diagnostics Market Set to Reach US$ 280.37 Billion by 2030 with Illumina, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN, Roche, Pfizer, Koninklijke Philips,& bioMérieux Leading [Yahoo! Finance]Yahoo! Finance
- Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website